DIANA Biotechnologies (Biopharma, Biotechnology) — Funding, Investors & Signals 2026

DIANA Biotechnologies

DIANA Biotechnologies: Diversified Biotech

Founded 2018

Czech Republic 60 employees Seed Total: $3.50M Biopharma, Biotechnology +1

DIANA Biotechnologies, with the slogan "Advancing clinical diagnostics and drug discovery," is a leading Czech biotechnology company that was founded in 2018. The company has made significant strides in the development of products based on cutting-edge research in molecular diagnostics and drug discovery. Notably, during the COVID-19 pandemic, DIANA rapidly developed one of the most innovative COVID-19 tests worldwide, becoming the largest Czech manufacturer of RT-PCR tests and greatly contributing to increasing the country's testing capacity. The company's focus extends beyond COVID-19, with ongoing projects seeking to develop new molecular diagnostics, monoclonal antibodies, and new drug candidates. DIANA attributes its success to a multidisciplinary team dedicated to advancing diagnostics and drug discovery. Despite being a young and dynamic company, it has already grown to a mid-sized organization of about 100 employees. Positioned as a first-of-its-kind biotech company in the Czech Republic, DIANA Biotechnologies is supported by a friendly and highly skilled team and has the capacity to drive long-term, ambitious projects. The company's significant growth and potential have attracted investment, with the latest being a €3.50MSeed Round investment from bpd partners a.s. that took place on 01 January 2018. DIANA's ambitious vision, innovative achievements, and global aspirations make it a compelling prospect for venture capital investors seeking to tap into the burgeoning biotechnology, pharmaceutical, and biopharma industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	••••••	1		01 Jan 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

••••••

01 Jan 2018

FAQ About DIANA Biotechnologies

DIANA Biotechnologies: Diversified Biotech

DIANA Biotechnologies was founded in 2018.

DIANA Biotechnologies is headquartered in Czech Republic.

DIANA Biotechnologies operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.

DIANA Biotechnologies has approximately 60 employees.

DIANA Biotechnologies has completed 1 funding round, raising a total of $3.50M. The latest funding stage is Seed.

Top alternatives and competitors to DIANA Biotechnologies include BioDot, Inc, NCF Diagnostics & DNA Technologies, Innovative Diagnostics, BioGX, Goldbug Strategies LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

DIANA Biotechnologies and BioDot, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

DIANA Biotechnologies

General Information

Track DIANA Biotechnologies

Discover More

About DIANA Biotechnologies

Funding Rounds & Investors (1)

DIANA Biotechnologies Alternatives & Competitors

FAQ About DIANA Biotechnologies

Don't just browse. Track.